<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Grzanka M</submitter><funding>The National Science Center, Poland</funding><pagination>3262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8955189</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(6)</volume><pubmed_abstract>Extracellular vesicles (EVs) are small, membranous structures involved in intercellular communication. Here, we analyzed the effects of thyroid cancer-derived EVs on the properties of normal thyroid cells and cells contributing to the tumor microenvironment. EVs isolated from thyroid cancer cell lines (CGTH, FTC-133, 8505c, TPC-1 and BcPAP) were used for treatment of normal thyroid cells (NTHY), as well as monocytes and endothelial cells (HUVEC). EVs' size/number were analyzed by flow cytometry and confocal microscopy. Gene expression, protein level and localization were investigated by qRT-PCR, WB and ICC/IF, respectively. Proliferation, migration and tube formation were analyzed. When compared with NTHY, CGTH and BcPAP secreted significantly more EVs. Treatment of NTHY with cancer-derive</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Extracellular Vesicles as Signal Carriers in Malignant Thyroid Tumors?</pubmed_title><pmcid>PMC8955189</pmcid><funding_grant_id>2016/21/B/NZ5/00063</funding_grant_id><pubmed_authors>Grzanka M</pubmed_authors><pubmed_authors>Gajda E</pubmed_authors><pubmed_authors>Czarnocka B</pubmed_authors><pubmed_authors>Stachurska-Skrodzka A</pubmed_authors><pubmed_authors>Adamiok-Ostrowska A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extracellular Vesicles as Signal Carriers in Malignant Thyroid Tumors?</name><description>Extracellular vesicles (EVs) are small, membranous structures involved in intercellular communication. Here, we analyzed the effects of thyroid cancer-derived EVs on the properties of normal thyroid cells and cells contributing to the tumor microenvironment. EVs isolated from thyroid cancer cell lines (CGTH, FTC-133, 8505c, TPC-1 and BcPAP) were used for treatment of normal thyroid cells (NTHY), as well as monocytes and endothelial cells (HUVEC). EVs' size/number were analyzed by flow cytometry and confocal microscopy. Gene expression, protein level and localization were investigated by qRT-PCR, WB and ICC/IF, respectively. Proliferation, migration and tube formation were analyzed. When compared with NTHY, CGTH and BcPAP secreted significantly more EVs. Treatment of NTHY with cancer-derive</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T07:45:22.823Z</modification><creation>2025-04-04T07:45:22.823Z</creation></dates><accession>S-EPMC8955189</accession><cross_references><pubmed>35328683</pubmed><doi>10.3390/ijms23063262</doi></cross_references></HashMap>